Ixabepilone and international normalised ratio increased Patient Reports February 10, 2012

Ixabepilone Side Effects Report #5474675-2
Ixabepilone side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Ixabepilone. After drug was administered, patient experienced the following side effects: febrile neutropenia, international normalised ratio increased. Ixabepilone dosage: unknown. During the same period patient was treated with CETUXIMAB, REGLAN, MEGACE, SENOKOT. Patient was hospitalized. Patient recovered.

Ixabepilone Side Effects Report #5479607-9
Ixabepilone side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Ixabepilone. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension, hypoxia, international normalised ratio increased, respiratory failure. Ixabepilone dosage: unknown. During the same period patient was treated with CETUXIMAB, REGLAN, MEGACE, SENOKOT. Patient was hospitalized. Patient died on 09/30/2007.

Ixabepilone Side Effects Report #5484070-8
Ixabepilone side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Ixabepilone. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension, hypoxia, international normalised ratio increased, respiratory failure. Ixabepilone dosage: unknown. During the same period patient was treated with CETUXIMAB, REGLAN, MEGACE, SENOKOT, MORPHINE, PROCHLORPERAZINE, CEFTAZIDIME. Patient was hospitalized. Patient died on 09/30/2007.

Ixabepilone Side Effects Report #5531234-0
Ixabepilone side effect was reported by a Health Professional from UNITED STATES on Nov 29, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Ixabepilone. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension, hypoxia, international normalised ratio increased, malignant neoplasm progression, respiratory failure. Ixabepilone dosage: unknown. During the same period patient was treated with CETUXIMAB, REGLAN, MEGACE, SENOKOT, MORPHINE, PROCHLORPERAZINE, CEFTAZIDIME. Patient was hospitalized. Patient died on 09/30/2007.